EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Significance of Thyroid 123I- Meta-Iodobenzylguanidine Uptake in Parkinson’s Disease

Sang-Won Yoo, Dong-Woo Ryu, Yoonsang Oh, Seunggyun Ha, Joong-Seok Kim

Journal of Movement Disorders · 31.07.2026 · 19 (3) · 295-303

DOI: 10.14802/jmd.26046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Movement Disorders, erschienen am 31.07.2026. Verfasst von Sang-Won Yoo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea National Institute of Health, National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The thyroid gland receives sympathetic innervation. 123I-meta-iodobenzylguanidine (123I-MIBG) is a noradrenaline analog taken up by adrenergic nerve terminals. Although thyroid uptake can be detected on 123I-MIBG scintigraphy, its quantitative value is poorly understood. This study examined the clinical relevance of thyroid 123I-MIBG uptake in Parkinson’s disease (PD).

Methods

A total of 233 de novo patients were enrolled in a longitudinal cohort and underwent 123I-MIBG scintigraphy. Early and late heart-to-mediastinum ratios (HMRs) and early thyroid-to-mediastinum ratios (TMRs) were calculated. Baseline TMRs were estimated using a mixed model after verifying the empirical linear decline over time. Observed and model-implied uptake ratios were analyzed in relation to adrenergic blood pressure (BP) control, motor and nonmotor burdens, and quality of life (QoL). Baseline thyroid uptake was further assessed for its influence on longitudinal disease progression.

Results

Patients were assessed for early PD (mean age, 68.7±8.7 years; median disease duration, 1.0 years). The mean follow-up was 57.3±22.1 months. A lower baseline HMR correlated with greater changes in orthostatic BP, greater autonomic symptom burden, and worse motor and nonmotor functions and QoL. Overall, the TMR was not significantly correlated; however, it was associated with a greater occurrence of supine hypertension, orthostatic hypotension, and nondipper or nocturnal hypertension. Thyroid uptake did not influence longitudinal changes in motor, nonmotor, cognitive, or QoL measures, although higher uptake tended to be associated with slower cognitive decline and better QoL.

Conclusion

Thyroid 123I-MIBG uptake did not predict disease progression but may indicate early blood pressure dysregulation and could reflect nonmotor vulnerability in PD patients.

Schlagwörter

Stichwörter der Autor:innen

123I-MIBG myocardial scintigraphyDysautonomiaParkinson’s diseaseSympathetic innervationThyroid uptake

Autor:innen und Institutionen

  • Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Division of Nuclear Medicine, Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea. neuronet@catholic.ac.kr.

Förderung

  • Korea National Institute of Health
  • National Research Foundation of Korea
  • Ministry of Education
  • Ministry of Science and ICT
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Yoo, S. W., Ryu, D. W., Oh, Y., Ha, S., & Kim, J. S. (2026). Clinical Significance of Thyroid 123I- Meta-Iodobenzylguanidine Uptake in Parkinson’s Disease. Journal of Movement Disorders, 19(3), 295-303. https://doi.org/10.14802/jmd.26046

Vancouver

Yoo SW, Ryu DW, Oh Y, Ha S, Kim JS. Clinical Significance of Thyroid 123I- Meta-Iodobenzylguanidine Uptake in Parkinson’s Disease. Journal of Movement Disorders. 2026;19(3):295-303. doi:10.14802/jmd.26046

BibTeX
@article{Yoo2026,
  author = {Yoo, Sang-Won and Ryu, Dong-Woo and Oh, Yoonsang and Ha, Seunggyun and Kim, Joong-Seok},
  title = {Clinical Significance of Thyroid 123I- Meta-Iodobenzylguanidine Uptake in Parkinson’s Disease},
  journal = {Journal of Movement Disorders},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {295--303},
  doi = {10.14802/jmd.26046}
}
Kostenlos starten →